Omslagafbeelding van de show Med wonks

Med wonks

Podcast door Dr. Matt Bezzant, MD

Engels

Technologie en Wetenschap

Tijdelijke aanbieding

2 maanden voor € 1

Daarna € 9,99 / maandElk moment opzegbaar.

  • 20 uur luisterboeken / maand
  • Podcasts die je alleen op Podimo hoort
  • Gratis podcasts
Begin hier

Over Med wonks

Have you ever wanted to ask your doctor a question but not had the time or opportunity to ask it? Looking for a straight answer when you ask difficult questions about healthcare? Here's your chance! Sit down with Tatumn, Krista and Dr. Matt for candid answers to your questions about healthcare, health, medicine and anything even tangentially related.

Alle afleveringen

3 afleveringen

aflevering America's drug problem artwork

America's drug problem

We dive into the pharmaceutical industry, so buckle up! As a side note, we reference Karendia (finerinone) as an expensive drug (around $800 a month list price) with minimal benefits. It provides 3-4% reduction in people having decreases in their GFR (a measure of kidney function) over 4 years, but no benefits in death, kidney failure, hospitalizations, heart attacks, strokes or any of the other things they measured. This is one of the medications that is being pushed on everyone with kidney disease but really is far too expensive to make sense with that little benefit. It would cost over $1,000,000 over 4 years for 1 person in 30 to not have a 40% reduction in the GFR with no other appreciable benefits. Here's the trial - https://www.nejm.org/doi/full/10.1056/NEJMoa2025845 References: https://repository.si.edu/bitstream/handle/10088/97768/Daemmrich%20PharmaMfg%20PharmHist%202017.pdf?sequence=1 [https://repository.si.edu/bitstream/handle/10088/97768/Daemmrich%20PharmaMfg%20PharmHist%202017.pdf?sequence=1] - history of pharmaceutical manufacturing https://pharmaphorum.com/r-d/a_history_of_the_pharmaceutical_industry [https://pharmaphorum.com/r-d/a_history_of_the_pharmaceutical_industry] - more history https://jamanetwork.com/journals/jama-health-forum/fullarticle/2811344 [https://jamanetwork.com/journals/jama-health-forum/fullarticle/2811344] - PBMs https://www.help.senate.gov/imo/media/doc/big_pharmas_business_model_report.pdf [https://www.help.senate.gov/imo/media/doc/big_pharmas_business_model_report.pdf] - profits in Pharma https://www.fda.gov/drugs/special-features/manufacturers-mouth-your-ears-direct-consumer-advertising [https://www.fda.gov/drugs/special-features/manufacturers-mouth-your-ears-direct-consumer-advertising] - DTC advertising https://www.propublica.org/article/doctors-prescribe-more-of-a-drug-if-they-receive-money-from-a-pharma-company-tied-to-it [https://www.propublica.org/article/doctors-prescribe-more-of-a-drug-if-they-receive-money-from-a-pharma-company-tied-to-it] - Doctors’ prescribing patterns https://lowninstitute.org/more-than-half-of-doctors-receive-industry-payments-with-some-making-millions/ [https://lowninstitute.org/more-than-half-of-doctors-receive-industry-payments-with-some-making-millions/] - industry payments https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378 [https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378] - drug research money source https://www.raps.org/news-and-articles/news-articles/2019/4/how-biopharma-companies-use-nih-and-vice-versa [https://www.raps.org/news-and-articles/news-articles/2019/4/how-biopharma-companies-use-nih-and-vice-versa] - NIH royalties https://www.gao.gov/prescription-drug-spending [https://www.gao.gov/prescription-drug-spending] - Govt prescription spending https://oig.hhs.gov/reports-and-publications/featured-topics/drug-spending/ [https://oig.hhs.gov/reports-and-publications/featured-topics/drug-spending/] - Govt drug spending https://www.aafp.org/pubs/afp/afp-community-blog/entry/will-the-high-price-of-gene-therapy-for-sickle-cell-disease-put-this-cure-out-of-reach.html#:~:text=The%20approval%20of%20Casgevy%2C%20which,distributional%20cost%2Deffectiveness%20analysis%20standards [https://www.aafp.org/pubs/afp/afp-community-blog/entry/will-the-high-price-of-gene-therapy-for-sickle-cell-disease-put-this-cure-out-of-reach.html#:~:text=The%20approval%20of%20Casgevy%2C%20which,distributional%20cost%2Deffectiveness%20analysis%20standards]. - sickle cell example https://www.fiercepharma.com/pharma/top-20-pharma-companies-2023-revenue [https://www.fiercepharma.com/pharma/top-20-pharma-companies-2023-revenue] - Pharma Revenue https://www.npr.org/2024/04/12/1244509038/u-s-drug-makers-see-big-profits-but-many-pay-taxes-far-below-the-corporate-rate [https://www.npr.org/2024/04/12/1244509038/u-s-drug-makers-see-big-profits-but-many-pay-taxes-far-below-the-corporate-rate] - drug company taxes https://www.gao.gov/products/gao-18-40 [https://www.gao.gov/products/gao-18-40] - drug company profit margins https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690298/ [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690298/] - History of drug advertising https://www.pharmacytimes.com/view/are-pbms-downplaying-their-profits [https://www.pharmacytimes.com/view/are-pbms-downplaying-their-profits] - PBM profits https://www.nbcnews.com/health/health-news/gaming-us-patent-system-keeping-drug-prices-sky-high-report-says-rcna47507 [https://www.nbcnews.com/health/health-news/gaming-us-patent-system-keeping-drug-prices-sky-high-report-says-rcna47507] - “Evergreening” and patent thickets

18 dec 2024 - 1 h 33 min
aflevering Follow the money artwork

Follow the money

Tatumn, Krista and Matt cover a broad overview of the perverse incentives in American healthcare and the many parties involved in making it happen. Resources: https://www.commonwealthfund.org/publications/fund-reports/2024/sep/mirror-mirror-2024?utm_source=twitter&utm_medium=social&utm_campaign=Improving+Health+Care+Quality [https://www.commonwealthfund.org/publications/fund-reports/2024/sep/mirror-mirror-2024?utm_source=twitter&utm_medium=social&utm_campaign=Improving+Health+Care+Quality] - America vs peer countries https://data.worldbank.org/indicator/SP.DYN.LE00.IN?end=2022&most_recent_value_desc=true&start=1960&view=chart [https://data.worldbank.org/indicator/SP.DYN.LE00.IN?end=2022&most_recent_value_desc=true&start=1960&view=chart] - world bank life expectancy  https://www.pgpf.org/blog/2024/08/how-does-the-us-healthcare-system-compare-to-other-countries#:~:text=In%202022%2C%20the%20United%20States,per%20capita%20across%20similar%20countries [https://www.pgpf.org/blog/2024/08/how-does-the-us-healthcare-system-compare-to-other-countries#:~:text=In%202022%2C%20the%20United%20States,per%20capita%20across%20similar%20countries]. - US spending per capita  https://www.definitivehc.com/blog/the-difference-between-non-profit-and-for-profit-hospitals [https://www.definitivehc.com/blog/the-difference-between-non-profit-and-for-profit-hospitals] - non-profit vs for-profit hospitals https://lowninstitute.org/the-rising-danger-of-private-equity-in-healthcare/ [https://lowninstitute.org/the-rising-danger-of-private-equity-in-healthcare/] - private equity https://www.jabfm.org/content/early/2024/08/30/jabfm.2024.240187R0 [https://www.jabfm.org/content/early/2024/08/30/jabfm.2024.240187R0] - EHR burnout https://www.reuters.com/legal/litigation/healthcare-software-giant-epic-hit-with-lawsuit-over-us-patient-records-2024-09-23/ [https://www.reuters.com/legal/litigation/healthcare-software-giant-epic-hit-with-lawsuit-over-us-patient-records-2024-09-23/] - Epic lawsuit https://www.pgpf.org/blog/2023/04/almost-25-percent-of-healthcare-spending-is-considered-wasteful-heres-why [https://www.pgpf.org/blog/2023/04/almost-25-percent-of-healthcare-spending-is-considered-wasteful-heres-why] - waste in healthcare https://www.ama-assn.org/press-center/press-releases/ama-studies-show-continued-cost-burden-medical-liability-system [https://www.ama-assn.org/press-center/press-releases/ama-studies-show-continued-cost-burden-medical-liability-system] - malpractice burden on physicians https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048809/ [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048809/] - costs of litigation

23 okt 2024 - 1 h 10 min
aflevering The doctor can't see you now artwork

The doctor can't see you now

Dive into the primary care crisis with Tatumn, Krista and Dr. Matt. We discuss why it's so hard to get in to see a doctor and things fueling the primary care crisis in America. Links to research/resources: https://www.ecgmc.com/insights/whitepaper/the-waiting-game-new-patient-appointment-access-for-us-physicians [https://www.ecgmc.com/insights/whitepaper/the-waiting-game-new-patient-appointment-access-for-us-physicians] - appointment waiting times https://www.jucm.com/pros-and-cons-of-urgent-care-vs-primary-care-billing-for-urgent-care-services/ [https://www.jucm.com/pros-and-cons-of-urgent-care-vs-primary-care-billing-for-urgent-care-services/] - Cost of Urgent Care https://www.debt.org/medical/emergency-room-urgent-care-costs/ [https://www.debt.org/medical/emergency-room-urgent-care-costs/] - Urgent care vs ER costs https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/state-of-primary-care-workforce-2023.pdf [https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/state-of-primary-care-workforce-2023.pdf] - Primary care shortage https://link.springer.com/article/10.1007/s11606-022-07707-x [https://link.springer.com/article/10.1007/s11606-022-07707-x] - time for primary care visits https://www.jabfm.org/content/29/4/496.full [https://www.jabfm.org/content/29/4/496.full] - panel sizes https://jamanetwork.com/journals/jama-health-forum/fullarticle/2802144 [https://jamanetwork.com/journals/jama-health-forum/fullarticle/2802144] - appointment times https://www.usnews.com/news/best-states/articles/2020-03-17/10-states-with-the-longest-emergency-room-wait-times [https://www.usnews.com/news/best-states/articles/2020-03-17/10-states-with-the-longest-emergency-room-wait-times] - ER wait times

23 okt 2024 - 50 min
Meld je aan om te luisteren
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Super app. Onthoud waar je bent gebleven en wat je interesses zijn. Heel veel keuze!
Makkelijk in gebruik!
App ziet er mooi uit, navigatie is even wennen maar overzichtelijk.

Kies je abonnement

Meest populair

Tijdelijke aanbieding

Premium

20 uur aan luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

2 maanden voor € 1
Daarna € 9,99 / maand

Begin hier

Premium Plus

Onbeperkt luisterboeken

  • Podcasts die je alleen op Podimo hoort

  • Geen advertenties in Podimo shows

  • Elk moment opzegbaar

Probeer 7 dagen gratis
Daarna € 13,99 / maand

Probeer gratis

Alleen bij Podimo

Populaire luisterboeken

Begin hier

2 maanden voor € 1. Daarna € 9,99 / maand. Elk moment opzegbaar.